R24 GM069736/GM/NIGMS NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2006	4
2007	5
2008	12
2009	7
2010	8
2011	4
2012	4
2013	1
2014	1
2016	1
2021	0

1

Complement-targeted therapeutics.

Ricklin D, Lambris JD. Ricklin D, et al. Nat Biotechnol. 2007 Nov;25(11):1265-75. doi: 10.1038/nbt1342. Nat Biotechnol. 2007. PMID: 17989689 Free PMC article. Review.

2

Complement evasion by human pathogens.

Lambris JD, Ricklin D, Geisbrecht BV. Lambris JD, et al. Nat Rev Microbiol. 2008 Feb;6(2):132-42. doi: 10.1038/nrmicro1824. Nat Rev Microbiol. 2008. PMID: 18197169 Free PMC article. Review.

3

Recent developments in low molecular weight complement inhibitors.

Qu H, Ricklin D, Lambris JD. Qu H, et al. Mol Immunol. 2009 Dec;47(2-3):185-95. doi: 10.1016/j.molimm.2009.08.032. Epub 2009 Oct 2. Mol Immunol. 2009. PMID: 19800693 Free PMC article. Review.

4

Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?

Nilsson B, Korsgren O, Lambris JD, Ekdahl KN. Nilsson B, et al. Trends Immunol. 2010 Jan;31(1):32-8. doi: 10.1016/j.it.2009.09.005. Trends Immunol. 2010. PMID: 19836998 Free PMC article. Review.

5

Compstatin: a complement inhibitor on its way to clinical application.

Ricklin D, Lambris JD. Ricklin D, et al. Adv Exp Med Biol. 2008;632:273-92. doi: 10.1007/978-0-387-78952-1_20. Adv Exp Med Biol. 2008. PMID: 19025129 Free PMC article. Review.

6

Computational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases.

Bellows ML, Floudas CA. Bellows ML, et al. Curr Drug Targets. 2010 Mar;11(3):264-78. doi: 10.2174/138945010790711914. Curr Drug Targets. 2010. PMID: 20210752 Free PMC article. Review.

7

Computational methods in protein structure prediction.

Floudas CA. Floudas CA. Biotechnol Bioeng. 2007 Jun 1;97(2):207-13. doi: 10.1002/bit.21411. Biotechnol Bioeng. 2007. PMID: 17455371

8

Derivation of ligands for the complement C3a receptor from the C-terminus of C5a.

Halai R, Bellows-Peterson ML, Branchett W, Smadbeck J, Kieslich CA, Croker DE, Cooper MA, Morikis D, Woodruff TM, Floudas CA, Monk PN. Halai R, et al. Eur J Pharmacol. 2014 Dec 15;745:176-81. doi: 10.1016/j.ejphar.2014.10.041. Epub 2014 Oct 30. Eur J Pharmacol. 2014. PMID: 25446428 Free PMC article.

9

ASTRO-FOLD 2.0: an Enhanced Framework for Protein Structure Prediction.

Subramani A, Wei Y, Floudas CA. Subramani A, et al. AIChE J. 2012 May 1;58(5):1619-1637. doi: 10.1002/aic.12669. Epub 2011 May 31. AIChE J. 2012. PMID: 23049093 Free PMC article.

10

Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.

Croker DE, Monk PN, Halai R, Kaeslin G, Schofield Z, Wu MC, Clark RJ, Blaskovich MA, Morikis D, Floudas CA, Cooper MA, Woodruff TM. Croker DE, et al. Immunol Cell Biol. 2016 Sep;94(8):787-95. doi: 10.1038/icb.2016.43. Epub 2016 Apr 25. Immunol Cell Biol. 2016. PMID: 27108698 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results